Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 27, 2019

Primary Completion Date

January 24, 2022

Study Completion Date

January 24, 2022

Conditions
Agitation,PsychomotorDementia
Interventions
DRUG

Sublingual film containing Dexmedetomidine

Sublingual film containing Dexmedetomidine

DRUG

Sublingual Placebo Film

Sublingual placebo film that matches BXCL501

Trial Locations (5)

33016

BioXcel Clinical Research Site, Miami Lakes

33032

BioXcel Clinical Research Site, Homestead

48723

BioXcel Clinical Research Site, Caro

01103

BioXcel Clinical Research Site, Springfield

08755

BioXcel Clinical Research Site, Toms River

Sponsors
All Listed Sponsors
collaborator

Cognitive Research Corporation

INDUSTRY

lead

BioXcel Therapeutics Inc

INDUSTRY